Most Recent
The field of competitors in a four-way contest to run a shareholder class action against Downer EDI over a $40 million profit overstatement has narrowed with the consolidation of three cases, leaving one firm to face criticism over its comparative inexperience running group proceedings.
A $26 million settlement has been reached in a class action against Ardent Leisure alleging it misled shareholders about safety measures that were in place ahead of the 2016 tragedy at its Dreamworld theme park in Queensland which claimed four lives.
After being hit by a $200 million claim in Australia, infant formula company Care A2 Plus is asking the court to block US business partner Gensco from filing a second lawsuit in its home country, which it says is intended to "harass and split the resources" of CAP and its directors.
A court has found the managing director of teahouse franchise Chatime liable for the underpayment of staff, despite accepting that he believed the company's wage system was not unlawful.
Australian infant formula company Care A2 Plus has hit back at a $200 million lawsuit by US business partner Gensco, arguing the distributor did not properly execute the agreement at the heart of the dispute as allegations of phantom companies fly.
IG Markets has been hit with a second class action for offering “highly risky and unsuitable financial products” to retail investors, with a third competing proceeding in the works.
The Federal Court has granted a bid by plaintiffs in competing class actions against Downer EDI to transfer their cases to the Victoria Supreme Court, where a four-way contest will take place.
The High Court has dismissed a constitutional appeal by Irish insurer Zurich, clearing the way for a class action over an allegedly defective New Zealand apartment block to proceed in the NSW Supreme Court.
Piper Alderman has strengthened its real estate team, appointing a former Holding Redlich partner to its Brisbane office.
A judge has resigned before delivering judgment in litigation that went to trial in 2020, and the colleague assigned the unenviable task of issuing a ruling has taken a swipe at his departing peer, noting the absence of medical or other evidence to explain her "unwillingness" to see the case through.